SS

Satendra Singh

Director Director DIN 09648957
DIN 09648957 First appointment Jun 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2022
Shareholding value Locked Premium profile

About Satendra Singh

Data last updated:

Satendra Singh has 4 years in corporate governance. Formerly with 1 company, such as Rimedile Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09648957
Primary Designation Director
First Appointment 23 Jun 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director23 Jun 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rimedile Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Satendra Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satendra Singh

Satendra Singh has 4 years in corporate governance. Formerly with 1 company, such as Rimedile Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Satendra Singh is associated with 0 companies as a director.

Satendra Singh has expertise in General Business.

Satendra Singh has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available